title: Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland.
abstract: The incidence and outcome of group B streptococcal (GBS) sepsis were assessed prospectively between September 2011 and February 2015 in all tertiary care pediatric hospitals of Switzerland. We describe a low incidence of GBS early-onset sepsis (0.12/1000 livebirths) and a predominance of GBS late-onset sepsis (0.36/1000 livebirths), a pattern that has not been reported in other countries.
authors.affiliation: From the *Service of Neonatology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland; †Infectious Diseases Service, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland; ‡Division of Infectious Diseases, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland; §Department of Pediatrics, Children's Hospital Lucerne, Lucerne, Switzerland; ¶Department of Pediatrics, Inselspital, University of Bern, Bern, Switzerland; ‖Pediatric Infectious Diseases Unit, Children's Hospital of Geneva, University Hospitals of Geneva, Geneva, Switzerland; **Infectious Diseases and Vaccinology, University Children's Hospital Basel, Basel, Switzerland; ††Department of Pediatrics, Children's Hospital Aarau, Aarau, Switzerland; ‡‡Department of Infectious Diseases, Children's Hospital of Eastern Switzerland St. Gallen, St. Gallen, Switzerland; §§Department of Neonatology, University Hospital Zurich, Zurich, Switzerland; ¶¶Department of Pediatrics, Children's Hospital Chur, Chur, Switzerland; ‖‖Paediatric Critical Care Research Group, Mater Research Institute, University of Queensland, Brisbane, Australia; and ***Paediatric Intensive Care Unit, Lady Cilento Children's Hospital, Children's Health Queensland, Brisbane, Australia.
authors.forename: Eric
authors.initials: E
authors.lastname: Giannoni
authors.forename: Christoph
authors.initials: C
authors.lastname: Berger
authors.forename: Martin
authors.initials: M
authors.lastname: Stocker
authors.forename: Philipp
authors.initials: P
authors.lastname: Agyeman
authors.forename: Klara M
authors.initials: KM
authors.lastname: Posfay-Barbe
authors.forename: Ulrich
authors.initials: U
authors.lastname: Heininger
authors.forename: Gabriel
authors.initials: G
authors.lastname: Konetzny
authors.forename: Anita
authors.initials: A
authors.lastname: Niederer-Loher
authors.forename: Christian
authors.initials: C
authors.lastname: Kahlert
authors.forename: Alex
authors.initials: A
authors.lastname: Donas
authors.forename: Antonio
authors.initials: A
authors.lastname: Leone
authors.forename: Paul
authors.initials: P
authors.lastname: Hasters
authors.forename: Christa
authors.initials: C
authors.lastname: Relly
authors.forename: Walter
authors.initials: W
authors.lastname: Baer
authors.forename: Christoph
authors.initials: C
authors.lastname: Aebi
authors.forename: Luregn J
authors.initials: LJ
authors.lastname: Schlapbach
mesh_terms: D005260:Female; D006776:Hospitals, Pediatric; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011446:Prospective Studies; D018805:Sepsis / Q000453:epidemiology* / Q000382:microbiology / Q000401:mortality*; D013290:Streptococcal Infections / Q000453:epidemiology* / Q000382:microbiology / Q000401:mortality*; D013292:Streptococcus agalactiae / Q000302:isolation & purification*; D013557:Switzerland / Q000453:epidemiology; D062606:Tertiary Care Centers; D016896:Treatment Outcome